Skip to content

Main Navigation

Omniabio
  • Home
  • CDMO Services
    • Services overview
    • Platform Leadership
    • Extensive Expertise
    • Case Studies
  • Manufacturing Infrastructure
    • Infrastructure Overview
    • Facilities by project stage
  • News
    • News Releases
    • OmniaBio in the News
    • Recent Highlights
  • Events
  • Careers
  • Contact Us
  • Mailing list

NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada.

Posted on December 1, 2022 (December 1, 2022) by jpearl

Post navigation

 OmniaBio celebrates the beginning of construction.OmniaBio Inc. announces private investor. 
© 2023 OmniaBio Inc.
Privacy Policy